Ilka Ott

9.9k total citations · 2 hit papers
144 papers, 6.3k citations indexed

About

Ilka Ott is a scholar working on Cardiology and Cardiovascular Medicine, Surgery and Hematology. According to data from OpenAlex, Ilka Ott has authored 144 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Cardiology and Cardiovascular Medicine, 56 papers in Surgery and 40 papers in Hematology. Recurrent topics in Ilka Ott's work include Cardiac Valve Diseases and Treatments (30 papers), Coronary Interventions and Diagnostics (24 papers) and Acute Myocardial Infarction Research (24 papers). Ilka Ott is often cited by papers focused on Cardiac Valve Diseases and Treatments (30 papers), Coronary Interventions and Diagnostics (24 papers) and Acute Myocardial Infarction Research (24 papers). Ilka Ott collaborates with scholars based in Germany, United States and Netherlands. Ilka Ott's co-authors include Albert Schömig, Meinrad Gawaz, Adnan Kastrati, Franz‐Josef Neumann, Massimiliano Fusaro, Karl‐Ludwig Laugwitz, Robert A. Byrne, Tareq Ibrahim, Franz‐Josef Neumann and Steffen Maßberg and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Ilka Ott

141 papers receiving 6.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial

2012 313 citations Robert A. Byrne, Franz–Josef Neumann et al. profile →
Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation

2015 287 citations K. Anette Fiedler, Michael Mæng et al. Journal of the American College of Cardiology profile →

Peers

Countries citing papers authored by Ilka Ott

Since Specialization

Citations

This map shows the geographic impact of Ilka Ott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ilka Ott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ilka Ott more than expected).

Fields of papers citing papers by Ilka Ott

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ilka Ott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ilka Ott. The network helps show where Ilka Ott may publish in the future.

Co-authorship network of co-authors of Ilka Ott

This figure shows the co-authorship network connecting the top 25 collaborators of Ilka Ott. A scholar is included among the top collaborators of Ilka Ott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ilka Ott. Ilka Ott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Differential Effects of Erythropoietin Administration and Overexpression on Venous Thrombosis in Mice 2023 ·Thrombosis and Haemostasis ·Sven Stockhausen, Badr Kilani, Irene Schubert, (unknown), Sue Chandraratne, (unknown), (unknown), Marie-Luise von Brühl, Steffen Maßberg, Ilka Ott, Konstantin Stark	3
2	Frequency of subclavian artery stenosis in patients with mammarian artery coronary bypass and suspected coronary artery disease progression 2022 ·Clinical Research in Cardiology ·(unknown), (unknown), Christian Bradaric, Tobias Koppara, Salvatore Cassese, Erion Xhepa, (unknown), Ilka Ott, Adnan Kastrati, Karl‐Ludwig Laugwitz, Tareq Ibrahim, Ralf J. Dirschinger	0
3	Outcomes of endovascular treatment for infrapopliteal peripheral artery disease based on the updated TASC II classification 2020 ·Vascular Medicine ·(unknown), (unknown), Christian Bradaric, Tobias Koppara, Victoria Kehl, Massimiliano Fusaro, Salvatore Cassese, Ilka Ott, Adnan Kastrati, Karl‐Ludwig Laugwitz, Tareq Ibrahim	8
4	Patient-specific catheter shaping for the minimally invasive closure of the left atrial appendage 2018 ·International Journal of Computer Assisted Radiology and Surgery ·(unknown), Ilka Ott, (unknown), Félix Bourier, Tim C. Lueth	1
5	Drug-eluting stents versus bare metal stents for the prevention of restenosis in patients with renovascular disease 2017 ·EuroIntervention ·Christian Bradaric, (unknown), (unknown), Michael Dommasch, (unknown), Nicolas Langwieser, Bernhard Haller, Ilka Ott, Massimiliano Fusaro, Uwe Heemann, Karl‐Ludwig Laugwitz, Adnan Kastrati, Tareq Ibrahim	12
6	Duration of Triple Therapy in Patients Requiring Oral Anticoagulation After Drug-Eluting Stent Implantation breakdown → 2015 ·Journal of the American College of Cardiology ·K. Anette Fiedler, Michael Mæng, Julinda Mehilli, Stefanie Schüpke, Robert A. Byrne, Dirk Sibbing, Petra Hoppmann, Simon Schneider, Massimiliano Fusaro, Ilka Ott, Steen Dalby Kristensen, Tareq Ibrahim, Steffen Maßberg, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati, Nikolaus Sarafoff	287
7	Acute and Midterm Outcome After MitraClip Therapy in Patients With Severe Mitral Regurgitation and Left Ventricular Dysfunction 2015 ·The American Journal of Cardiology ·(unknown), Carolin Sonne, Daniel Braun, Martin Orban, Jürgen Pache, Adnan Kastrati, Albert Schömig, Julinda Mehilli, Petra Barthel, Ilka Ott, (unknown), Steffen Maßberg, Jörg Hausleiter	22
8	Standardized methodology for transfemoral transcatheter aortic valve replacement with the Edwards Sapien XT valve under fluoroscopy guidance. 2014 ·PubMed ·Albert Markus Kasel, (unknown), Stephan Schneider, (unknown), (unknown), Christof Burgdorf, Ilka Ott, (unknown), Adnan Kastrati, Wolfgang von Scheidt, Christian Thilo	16
9	[New ESH/ESC guidelines on arterial hypertension : what is new and what indications remain for renal denervation?]. 2014 ·Herz ·(unknown), Sebastian Kufner, Ilka Ott, Heribert Schunkert	1
10	Prognostic role of restenosis in 10 004 patients undergoing routine control angiography after coronary stenting 2014 ·European Heart Journal ·Salvatore Cassese, Robert A. Byrne, Stephanie Schulz, (unknown), (unknown), (unknown), Tareq Ibrahim, Ilka Ott, Massimiliano Fusaro, Heribert Schunkert, Karl‐Ludwig Laugwitz, Adnan Kastrati	86
11	Valve-in-valve transfemoral TAVR: Sapien 3 valve within a failed core valve bioprosthesis 2014 ·European Heart Journal ·(unknown), Ilka Ott, A. Kastrati, Albert Markus Kasel	3
12	Risk of Stent Thrombosis Among Bare-Metal Stents, First-Generation Drug-Eluting Stents, and Second-Generation Drug-Eluting Stents 2013 ·JACC: Cardiovascular Interventions ·Tomohisa Tada, Robert A. Byrne, Iva Šimunović, Lamin King, Salvatore Cassese, Michael Joner, Massimiliano Fusaro, Simon Schneider, S. Schulz, Tareq Ibrahim, Ilka Ott, Steffen Maßberg, Karl‐Ludwig Laugwitz, Adnan Kastrati	234
13	Paclitaxel-coated balloon or primary bare nitinol stent for revascularization of femoropopliteal artery: A meta-analysis of randomized trials versus uncoated balloon and an adjusted indirect comparison 2013 ·International Journal of Cardiology ·Massimiliano Fusaro, Salvatore Cassese, Gjin Ndrepepa, Lamin King, Tomohisa Tada, Ilka Ott, Adnan Kastrati	32
14	Bleeding after percutaneous coronary intervention in women and men matched for age, body mass index, and type of antithrombotic therapy 2013 ·American Heart Journal ·Gjin Ndrepepa, S. Schulz, Franz‐Josef Neumann, Robert A. Byrne, Petra Hoppmann, Salvatore Cassese, Ilka Ott, Massimiliano Fusaro, Tareq Ibrahim, Tomohisa Tada, Gert Richardt, Karl‐Ludwig Laugwitz, Heribert Schunkert, Adnan Kastrati	31
15	Prognostic value of sensitive troponin T in patients with stable and unstable angina and undetectable conventional troponin 2010 ·American Heart Journal ·Gjin Ndrepepa, Siegmund Braun, Julinda Mehilli, K. Anette Birkmeier, Robert A. Byrne, Ilka Ott, (unknown), S. Schulz, Massimiliano Fusaro, Jürgen Pache, Jörg Hausleiter, Karl‐Ludwig Laugwitz, Steffen Maßberg, Melchior Seyfarth, Albert Schömig, Adnan Kastrati	73
16	Tissue Factor–Factor VIIa complex induces cytokine expression in coronary artery smooth muscle cells 2010 ·Atherosclerosis ·(unknown), Isabell Seitz, (unknown), Birgit Steppich, (unknown), Richard Brandl, Albert Schömig, Ilka Ott	25
17	Circulating endothelial progenitor cells decrease in patients after endarterectomy 2008 ·Journal of Vascular Surgery ·(unknown), (unknown), Birgit Steppich, (unknown), Richard Brandl, Ilka Ott	10
18	Tissue Factor in Acute Coronary Syndromes 2003 ·Seminars in Vascular Medicine ·Ilka Ott	18
19	Effect of glycoprotein IIb/IIIa receptor blockade on platelet-leukocyte interaction and surface expression of the leukocyte integrin Mac-1 in acute myocardial infarction 1999 ·Journal of the American College of Cardiology ·F. Neumann, Dietlind Zohlnhöfer, (unknown), Ilka Ott, Meinrad Gawaz, (unknown)	192
20	Prospective evaluation of hemostatic predictors of subacute stent thrombosis after coronary palmaz-schatz stenting 1996 ·Journal of the American College of Cardiology ·Franz–Josef Neumann, Meinrad Gawaz, Ilka Ott, Andreas E. May, (unknown), Albert Schömig	79

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact